Free Trial

Cardiol Therapeutics (CRDL) Competitors

Cardiol Therapeutics logo
C$1.46 -0.08 (-5.19%)
As of 10/10/2025 04:00 PM Eastern

CRDL vs. FRX, VBV, CUS, AIM, GPH, IPA, APM, GXE, CGC, and MDNA

Should you be buying Cardiol Therapeutics stock or one of its competitors? The main competitors of Cardiol Therapeutics include Fennec Pharmaceuticals (FRX), VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), Aimia (AIM), Graphite One (GPH), ImmunoPrecise Antibodies (IPA), Andean Precious Metals (APM), Gear Energy (GXE), Canadian Gold (CGC), and Medicenna Therapeutics (MDNA). These companies are all part of the "pharmaceutical products" industry.

Cardiol Therapeutics vs. Its Competitors

Fennec Pharmaceuticals (TSE:FRX) and Cardiol Therapeutics (TSE:CRDL) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.

In the previous week, Fennec Pharmaceuticals had 13 more articles in the media than Cardiol Therapeutics. MarketBeat recorded 13 mentions for Fennec Pharmaceuticals and 0 mentions for Cardiol Therapeutics. Fennec Pharmaceuticals' average media sentiment score of 0.52 beat Cardiol Therapeutics' score of 0.00 indicating that Fennec Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
Fennec Pharmaceuticals Positive
Cardiol Therapeutics Neutral

Fennec Pharmaceuticals has a beta of 2.479494, indicating that its share price is 148% more volatile than the S&P 500. Comparatively, Cardiol Therapeutics has a beta of 0.855752, indicating that its share price is 14% less volatile than the S&P 500.

Cardiol Therapeutics has a net margin of 0.00% compared to Fennec Pharmaceuticals' net margin of -2.30%. Fennec Pharmaceuticals' return on equity of 29.94% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Fennec Pharmaceuticals-2.30% 29.94% 8.88%
Cardiol Therapeutics N/A -195.07%-54.15%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fennec Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00
Cardiol Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Fennec Pharmaceuticals has higher revenue and earnings than Cardiol Therapeutics. Fennec Pharmaceuticals is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fennec PharmaceuticalsC$33.30M10.28-C$800.44K-C$0.45-27.33
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.48-3.04

14.4% of Fennec Pharmaceuticals shares are held by institutional investors. Comparatively, 0.8% of Cardiol Therapeutics shares are held by institutional investors. 16.2% of Fennec Pharmaceuticals shares are held by insiders. Comparatively, 4.6% of Cardiol Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Fennec Pharmaceuticals beats Cardiol Therapeutics on 12 of the 14 factors compared between the two stocks.

Get Cardiol Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRDL vs. The Competition

MetricCardiol TherapeuticsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$122.24MC$1.73BC$6.05BC$9.53B
Dividend YieldN/A2.95%5.73%6.52%
P/E Ratio-3.04118.0785.1429.30
Price / SalesN/A1,637.07607.1712.90
Price / Cash0.9810.3725.7783.29
Price / Book9.7811.5012.645.73
Net Income-C$42.93MC$20.70BC$3.32BC$301.20M
7 Day Performance-2.67%-0.91%-0.07%-1.52%
1 Month Performance-3.31%3.15%8.70%4.35%
1 Year Performance-44.06%8.97%78.24%37.50%

Cardiol Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRDL
Cardiol Therapeutics
N/AC$1.46
-5.2%
N/A-44.1%C$122.24MN/A-3.0420
FRX
Fennec Pharmaceuticals
N/AC$13.29
+1.1%
N/AN/AC$369.89MC$33.30M-29.5310
VBV
VBI Vaccines
N/AN/AN/AN/AC$308.86MC$3.36M-4.9722
CUS
Chemtrade Electrochem Inc,
N/AN/AN/AN/AC$306.50MN/A0.0060
AIM
Aimia
2.4767 of 5 stars
C$3.16
-0.3%
C$4.00
+26.6%
+23.6%C$287.42MC$486.40M-39.5020Positive News
GPH
Graphite One
N/AC$1.38
-2.8%
N/A+96.5%C$222.26MN/A-23.0020Gap Up
High Trading Volume
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%
N/A+0.0%C$162.08MC$19.47M-7.3080Gap Down
APM
Andean Precious Metals
1.7445 of 5 stars
C$1.29
+7.5%
C$2.00
+55.0%
-27.1%C$135.47MC$154.78M2.5530Positive News
GXE
Gear Energy
N/AN/AN/AN/AC$126.52MC$134.93M10.391,310
CGC
Canadian Gold
N/AC$0.52
+6.1%
N/A+163.2%C$102.20MN/A-26.003,150
MDNA
Medicenna Therapeutics
N/AC$0.92
-1.1%
N/A-57.8%C$76.74MN/A-5.7520Gap Up

Related Companies and Tools


This page (TSE:CRDL) was last updated on 10/14/2025 by MarketBeat.com Staff
From Our Partners